Skip to content
GP Intel.
GPsCompaniesPricingAboutSign inStart free
All articles
Fund Analysis2026-05-12·12 min read

Eurazeo Fund Analysis · Track Record 2026

Inside Eurazeo's €36.8bn private markets platform: 31 funds, 183 active portfolio companies, 59 tracked exits across buyout, growth and secondaries.

GP
GP Intel Research
Private Equity Intelligence
EurazeoArdianTikehau Capital
AUM (latest)€36.8bn (Jun 2025)€196.0bn€47.0bn
ListedYes (Euronext Paris)No (partner-owned)Yes (Euronext Paris)
HQParis, FranceParis, FranceParis, France
Founded2001 (Eurafrance 1969)1996 (independent 2013)2004
Core strategiesBuyout, growth, secondaries, debt, RESecondaries, buyout, infra, debt, REPE, debt, real assets, capital markets
Active funds tracked313313
Active portfolio companies18323570
Realised exits tracked5925346
On this page
  • Eurazeo's positioning · a listed Euronext platform reaching €36.8bn AUM
  • Inside Eurazeo's investment strategy across buyout, growth and secondaries
  • Eurazeo's track record · 2023-2025 exits worth tracking
  • Where Eurazeo deploys capital · sector and geographic breakdown
  • Eurazeo's 2024-2027 strategic plan and recent fundraising
  • Eurazeo vs Ardian vs Tikehau · comparing France's listed alternatives platforms
  • How Eurazeo's listed structure shapes investment decisions
  • How to track Eurazeo's deals in real time

Eurazeo is one of the few European private equity firms operating as a listed permanent capital platform, combining balance-sheet investing with third-party fund management at scale. With €36.8 billion in assets under management as of June 2025, the Paris-based group is delivering on a 2024-2027 strategic plan focused on accelerated asset rotation, record fundraising and growing exposure to impact and wealth solutions.

This Eurazeo fund analysis breaks down the firm's positioning, investment strategy, recent track record, sector focus and current vintages, drawing on the live Eurazeo portfolio data tracked on GP Intel alongside primary disclosures from Eurazeo's investor relations, the Financial Times and Reuters.

Eurazeo's positioning · a listed Euronext platform reaching €36.8bn AUM

Eurazeo SE is structured as a listed holding company on Euronext Paris (ticker RF.PA), tracing its modern brand back to the 2001 merger of Eurafrance, a Paris holding company founded in 1969, with Azeo. The firm has progressively transformed from a pure principal investment vehicle into a hybrid model that combines €9.3 billion of balance-sheet capital with €27.5 billion of third-party assets under management as of mid-2025.

This dual structure differentiates Eurazeo from non-listed peers such as Ardian or PAI Partners, which rely entirely on closed-end fund commitments from institutional limited partners. The listed permanent capital base provides Eurazeo with optionality on holding periods, enabling longer-duration positions in conviction names and selective continuation vehicles when value-creation runways extend beyond the typical seven-year fund duration.

According to Eurazeo's 2025 strategic plan disclosures, the firm achieved record fundraising in 2024-2025 alongside €3.4 billion in realisations in 2024 (more than 2.5 times the 2023 level) and €1.9 billion in private equity exits during 2025 alone. The 14-office international footprint across Europe, Asia and the United States supports both deal sourcing and limited partner relations across more than 450 employees.

Inside Eurazeo's investment strategy across buyout, growth and secondaries

Eurazeo deploys capital across five complementary strategies, each managed by dedicated sector and geography teams within the broader Eurazeo group platform.

Mid-cap buyout is the historical flagship, targeting European mid-market companies in consumer, business services, healthcare and industrials with equity tickets typically between €150 million and €400 million. The strategy has built brand-defining positions in companies such as Moncler, Jacquemus and Vestiaire Collective.

Growth equity targets late-stage scaling businesses with a strong technology component, often co-investing with leading global growth investors. Eurazeo Growth II closed at €800 million and remains an active vintage, while the broader Venture franchise has invested in Doctolib and Cognigy ahead of their respective milestones.

Secondaries and Private Funds Group has expanded significantly to capture the structural growth in GP-led and LP-led secondary transactions across European mid-market private equity, providing liquidity solutions and continuation-fund execution alongside dedicated institutional capital.

Private debt complements the equity platforms with senior, unitranche and mezzanine financing solutions for mid-cap corporates and sponsor-backed transactions across Europe.

Real assets include real estate and infrastructure with selective sustainability themes, complementing the broader multi-strategy mandate.

A defining feature of the strategy is the impact and climate angle: dedicated impact AUM reached €5.7 billion by mid-2025, accounting for 15 percent of total Eurazeo AUM, with capital flowing to companies driving the energy transition, circular economy and inclusive economy themes.

Eurazeo's track record · 2023-2025 exits worth tracking

Asset rotation has been a strategic priority since the 2024-2027 plan launched, with Eurazeo accelerating distributions across its mature vintages. The cash-on-cash multiples disclosed publicly point to disciplined entry pricing and value creation, particularly in technology and healthcare verticals.

Ex Nihilo (consumer, 2026) was sold with a disclosed cash-on-cash multiple of approximately 2.7x, reflecting brand value creation in the luxury perfumery segment.

Cognigy (AI and machine learning, 2025) delivered a high-multiple realisation in conversational AI for enterprise customer service, ahead of broader market re-rating of pure-play AI software platforms.

Ultra Premium Direct (consumer, 2025) and Fermax (industrials, 2025) rounded out the 2025 realisations alongside other unannounced positions, contributing to the €1.9 billion private equity exit total for the year.

The 2024 vintage of exits delivered standout multiples: Amolyt Pharma (biopharma, 2024), Onfido (identity verification SaaS, 2024) and Lumapps (enterprise employee experience SaaS, 2024) each generated cash-on-cash multiples of approximately 4.0x, contributing materially to the €3.4 billion total realisation volume for 2024.

Cumulatively, GP Intel tracks 59 realised Eurazeo exits across vintages dating back to early 2000s buyouts. Pro subscribers can access exit buyer identities, sectors, dates and disclosed financial parameters across the full historical track record at €49 per month.

Where Eurazeo deploys capital · sector and geographic breakdown

Eurazeo's portfolio composition reflects a deliberate diversification across themes and stages. Active capital deployment skews toward five clusters:

  1. Consumer brands · premium and lifestyle positions including beauty, fashion, food and direct-to-consumer plays. Historical winners include Moncler, Jacquemus and Vestiaire Collective. Recent activity continues in selective scaling consumer platforms.
  2. Healthcare and life sciences · both buyout and venture exposure across biopharma, diagnostics and digital health. Doctolib stands as the platform's flagship healthtech investment.
  3. Industrials and energy transition · buyout positions in industrial businesses with consolidation upside, complemented by dedicated transition-themed vintage funds.
  4. Business services · outsourced services, software-enabled service businesses and B2B platforms.
  5. AI and enterprise software · growth and venture investments capturing the structural shift toward AI-augmented business workflows.

Geographically, Eurazeo deploys primarily across Western Europe (France, Italy, United Kingdom, Germany, Spain, Benelux, Nordics) with selective exposure to North America through dedicated US investment teams. The broader Eurazeo group platform leverages 14 offices spanning Europe, Asia and the United States.

Eurazeo's 2024-2027 strategic plan and recent fundraising

The 2024-2027 strategic plan articulated by Eurazeo focuses on three pillars: accelerating third-party fundraising, expanding wealth and impact AUM, and accelerating asset rotation through disciplined exit execution.

By Q1 2025, Eurazeo reported record fundraising momentum across its current vintage funds, with sustained inflows into the flagship buyout, growth, secondaries and private debt strategies. Per Eurazeo's Q1 2025 trading update, this fundraising pace underpins the AUM growth target through 2027.

The Eurazeo Private Value Europe 3 (EPVE 3) evergreen fund has emerged as a strategic differentiator, surpassing €3 billion in commitments by mid-2025 and receiving the "Best Private Market Product · Mass Affluent" award at IPEM in January 2025. The product opens institutional-grade private markets exposure to wealth advisory channels, a category Eurazeo has signalled as a long-term growth vector alongside traditional institutional limited partners.

Impact AUM is the second growth engine: reaching €5.7 billion by mid-2025 (up from €5.1 billion at end of 2024), the impact franchise targets the 15 percent of platform AUM milestone with continued vintage launches in climate and inclusion themes.

Eurazeo vs Ardian vs Tikehau · comparing France's listed alternatives platforms

Among Paris-headquartered private markets firms, three groups stand out by scale and platform breadth: Eurazeo, Ardian and Tikehau Capital. The structural differences shape investor access, fee economics and stakeholder governance.

Ardian is the largest by AUM (€196 billion) but is partner-owned rather than listed, following its 2013 independence from AXA. Its flagship secondaries franchise is the largest globally by deal volume, complemented by direct buyout, infrastructure, private debt and real estate. Ardian's scale enables it to execute fund-level GP-led and LP-led secondary transactions at sizes other firms cannot match.

Tikehau Capital is the closest peer to Eurazeo in structural terms: also listed on Euronext Paris, founded 2004, partnership-led with majority insider ownership and a similar multi-strategy mandate. Tikehau emphasises thematic focus on the energy transition, cybersecurity, aerospace and defence, with €47 billion in AUM as of December 2024.

Eurazeo sits in the middle in AUM terms but has the longest listed track record, the most diversified consumer and growth exposure, and the most developed wealth solutions product in EPVE 3. Each firm targets different operational levers: Ardian's secondaries network, Tikehau's thematic conviction, Eurazeo's listed permanent capital and consumer brand expertise.

The comparison table above summarises the headline data points, while detailed portfolio-level and exit-level data is available on the Eurazeo, Ardian and Tikehau Capital fiches on GP Intel.

How Eurazeo's listed structure shapes investment decisions

Operating as a listed entity introduces governance and disclosure obligations that distinguish Eurazeo from non-listed peers. Quarterly trading updates, half-year and full-year results disclose AUM trajectory, fundraising momentum, deployment activity and realisation volumes at the group level, with selective sub-strategy and impact AUM granularity.

This transparency creates a structural advantage for investors and limited partners conducting diligence: public access to consolidated AUM, fundraising progression, asset rotation pace and dividend policy provides ongoing visibility into firm-level execution. The listed share price (ticker RF.PA on Euronext Paris) also signals market views on the firm's outlook and provides a liquidity option absent from closed-end fund commitments.

The flip side is that listed equity capital implies cost of capital expectations from public shareholders, requiring Eurazeo to balance dividend distributions, share buybacks and reinvestment in the platform. The 2024-2027 strategic plan explicitly addresses this trade-off by targeting fee-related earnings growth while maintaining selective balance-sheet deployment in conviction names.

According to Financial Times coverage of European listed alternatives platforms, the structural differences between listed and non-listed asset managers continue to drive divergent capital allocation strategies, with listed players (Eurazeo, Tikehau, Wendel) navigating public market expectations alongside fund-level investor demands.

How to track Eurazeo's deals in real time

For dealmakers, limited partners and analysts seeking ongoing visibility into Eurazeo's portfolio activity, GP Intel maintains a live tracking surface at /gp/eurazeo covering:

  • 31 active fund vehicles with vintage, size and strategy classification
  • 183 active portfolio companies with sector, geography and entry date
  • 59 realised exits with buyer identity, year and sector (Pro tier)
  • Multiple disclosures on selected exits including cash-on-cash data (Pro tier)
  • Recent activity feed across portfolio, exits and fundraising milestones

The data is hand-checked against Eurazeo's official disclosures, regulatory filings and industry publications. Free browsing covers full directory access; Pro access at €49 per month unlocks exit buyer identities, financial multiples, Excel exports and watchlist functionality for active diligence workflows.

For broader market context, the European PE landscape 2026 overview compares Eurazeo with the wider universe of European private markets firms, while the PE fund due diligence checklist provides a structured framework for LPs assessing managers across the platform.

Eurazeo's combination of listed permanent capital, multi-strategy depth and accelerated asset rotation positions the firm as a distinctive name within European private markets. Whether tracking new deal flow, current portfolio composition or realised track record, the Eurazeo fiche on GP Intel remains the most current single source for live data on the firm.

Frequently Asked Questions

What is Eurazeo's AUM in 2025?

Eurazeo Group reported €36.8 billion in assets under management at the end of June 2025, up 4 percent over twelve months. Third-party AUM stood at €27.5 billion (up 10 percent), including approximately €5.5 billion in dry powder. The firm has set a 2027 strategic plan target of significantly higher AUM driven by fundraising momentum across mid-market, growth and impact strategies.

What sectors does Eurazeo invest in?

Eurazeo deploys capital across consumer, industrials, healthcare, business services and technology, with growing exposure to AI and machine learning through its venture and growth strategies. Climate and impact themes account for €5.7 billion in dedicated AUM (15 percent of total), reflecting a multi-vintage commitment to the energy transition.

Who are Eurazeo's largest portfolio companies?

Eurazeo's portfolio spans 183 active companies tracked on GP Intel, including consumer brands and high-growth technology businesses across Europe and North America. Historical investments have included Moncler, Jacquemus, Doctolib and Vestiaire Collective. Detailed real-time portfolio data is available on the [Eurazeo fiche](/gp/eurazeo), with exit buyer and multiple data accessible on Pro at €49 per month.

Eurazeo vs Ardian: what is the difference?

Both firms are Paris-headquartered and operate multi-strategy private markets platforms, but Ardian is larger (€196 billion AUM vs €36.8 billion) and partner-owned rather than listed. Ardian's flagship strategy is secondaries (the largest globally by deal volume), while Eurazeo balances buyout, growth, secondaries, private debt and real assets through its listed permanent capital structure on Euronext Paris.

When did Eurazeo go public on Euronext?

Eurazeo SE has been listed on Euronext Paris since the 2001 merger of Eurafrance (founded 1969 as a Paris-based holding company) with Azeo, which created the modern Eurazeo brand. The firm trades under the ticker RF.PA and has used its listed permanent capital base to invest alongside third-party institutional capital across successive fund vintages.

What are Eurazeo's most recent exits?

Recent realised exits include Ex Nihilo (consumer, 2026, with a disclosed cash-on-cash multiple of 2.7x), Cognigy (AI and machine learning, 2025), Ultra Premium Direct (consumer, 2025) and Fermax (industrials, 2025). In 2024, Eurazeo completed €3.4 billion in realisations, including Amolyt Pharma, Onfido and Lumapps with cash-on-cash multiples of approximately 4.0x. Private equity exits reached €1.9 billion in 2025 alone.

How does Eurazeo's evergreen wealth fund EPVE 3 work?

Eurazeo Private Value Europe 3 (EPVE 3) is a perpetual private markets fund designed for wealth and mass affluent investors, structured to invest alongside Eurazeo's institutional vehicles across European mid-market private equity, private debt and real assets. By mid-2025 the fund surpassed €3 billion in commitments, making it one of the largest private market evergreen funds in Europe.

Does Eurazeo invest in venture capital?

Yes. Eurazeo Venture has been an active platform for over a decade, with notable investments including Doctolib (one of Europe's most valuable healthtech companies) and Vestiaire Collective (luxury resale marketplace). The strategy targets late-stage growth equity across Europe and North America, complementing the buyout and growth platforms within the broader multi-strategy mandate.

Explore related

Browse Eurazeo full portfolioPE fund due diligence checklistEuropean PE landscape 2026Largest European GPs by AUM

Explore the GP Intel database

Access 1,000+ GP profiles, 21,000+ portfolio companies, and more.

Start free

Related Articles

Fund Analysis12 min read

Ardian Fund Analysis · Track Record 2026

Inside Ardian's €196bn private markets platform: 33 funds tracked, 235 active portfolio companies, 253 realised exits across secondaries, buyout, infra and debt.

Fund Analysis11 min read

Astorg Fund Analysis · Track Record 2026

Inside Astorg's €23bn European mid-market platform: 10 funds tracked, 34 active portfolio companies, 44 exits across B2B services, healthcare and technology.

Fund Analysis11 min read

Bpifrance Investissement Fund Analysis · 2026

Inside Bpifrance Investissement's French state strategic equity platform: 12 funds tracked including Lac1 €4.2bn, Mid Large, Capital Croissance and French Tech Acceleration vehicles.

GP Intel.

Open-data private equity intelligence. 1,000+ European PE firms, 21,000+ portfolio companies, verified exits. Finally done right.

Product

  • GP Database
  • Companies
  • Features
  • Pricing

Discover

  • By country
  • By sector
  • By strategy
  • Rankings
  • Blog
  • Glossary

Company

  • About
  • Methodology
  • Editorial standards
  • FAQ
  • Press
  • Contact
© 2026 GP Intel. All rights reserved.
TermsPrivacy